Analyst Price Targets — BIOX
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| January 2, 2026 11:24 am | Austin Moeller | Canaccord Genuity | $2.00 | $1.31 | TheFly | Bioceres price target lowered to $2 from $2.25 at Canaccord |
| September 10, 2025 12:24 pm | Ben Klieve | Lake Street | $5.00 | $2.06 | TheFly | Bioceres price target lowered to $5 from $8 at Lake Street |
| September 10, 2025 9:01 am | — | Canaccord Genuity | $2.50 | $2.06 | TheFly | Bioceres downgraded to Hold from Buy at Canaccord |
| September 9, 2025 6:40 pm | — | Oppenheimer | $5.00 | $2.24 | StreetInsider | Bioceres Crop Solutions (BIOX) PT Lowered to $5 at OppenheimerMember Login |
| October 21, 2024 7:33 am | Kristen Owen | Oppenheimer | $13.00 | $7.51 | StreetInsider | Bioceres Crop Solutions (BIOX) PT Lowered to $13 at Oppenheimer |
| September 11, 2024 8:17 am | Ben Klieve | Loop Capital Markets | $13.00 | $8.31 | StreetInsider | Bioceres Crop Solutions (BIOX) PT Lowered to $13 at Lake Street Capital Markets |
| September 11, 2024 8:01 am | Ben Klieve | Lake Street | $13.00 | $8.65 | TheFly | Bioceres price target lowered to $13 from $25 at Lake Street |
| September 11, 2024 6:57 am | Austin Moeller | Canaccord Genuity | $12.50 | $8.36 | StreetInsider | Bioceres Crop Solutions (BIOX) PT Lowered to $12.50 at Canaccord Genuity |
| September 10, 2024 4:03 pm | Kristen Owen | Oppenheimer | $16.00 | $8.65 | StreetInsider | Bioceres Crop Solutions (BIOX) PT Lowered to $16 at Oppenheimer |
| July 2, 2024 7:40 am | Scott Fortune | Roth Capital | $15.00 | $11.13 | TheFly | Bioceres resumed with a Buy at Roth MKM |
Latest News for BIOX
Bioceres Crop Solutions (NASDAQ: BIOX - Get Free Report) and Lavoro (NASDAQ: LVRO - Get Free Report) are both small-cap consumer staples companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, earnings, valuation, risk and dividends. Profitability This table compares Bioceres Crop
Moolec Science (NASDAQ: MLEC - Get Free Report) and Bioceres Crop Solutions (NASDAQ: BIOX - Get Free Report) are both small-cap consumer staples companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, institutional ownership, risk and valuation. Insider and Institutional Ownership 0.1%
Bioceres Crop Solutions (NASDAQ: BIOX - Get Free Report) and Davis Commodities (NASDAQ: DTCK - Get Free Report) are both small-cap consumer staples companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, earnings, analyst recommendations, institutional ownership, profitability, dividends and valuation. Profitability This table compares Bioceres
ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (NASDAQ: BIOX): Dear Fellow Shareholders, This communication accompanies the filing of our Form 6-K for the second quarter of fiscal year 2026, covering the six-month period ended 31 December 2025. I want to speak directly to our shareholders about where we stand, what we are focused on, and how we are navigating a period that has been both…
Bioceres Crop Solutions Corp. (NASDAQ: BIOX - Get Free Report) saw a large growth in short interest during the month of February. As of February 13th, there was short interest totaling 942,815 shares, a growth of 71.0% from the January 29th total of 551,455 shares. Approximately 1.5% of the company's shares are sold short. Based on
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for BIOX.
Senate Trading
No Senate trades found for BIOX.
U.S. House Trading
No House trades found for BIOX.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.